Biliary Tract Cancers | Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Research To Practice | Oncology Videos

Featuring slide presentations and related discussion from Dr Lipika Goyal, Dr James J Harding, Dr Milind Javle and Dr Robin K (Katie) Kelley, including the following topics:

• Current Role of Immunotherapeutic Strategies for Advanced Biliary Tract Cancers (BTCs) — Dr Kelley (0:00)
• Case: A man in his late 60s with advanced distal cholangiocarcinoma treated with the TOPAZ-1 regimen (13:27)
• Case: A woman in her early 70s with recurrent gallbladder cancer with biliary obstruction (15:56)
• Targeting FGFR and IDH Alterations for Advanced BTCs — Dr Goyal (35:00)
• Case: A woman in her late 30s with FGFR2 fusion-positive intrahepatic cholangiocarcinoma (ICC) (54:25)
• Case: A man in his late 60s with cholangiocarcinoma metastases to liver and bone (1:01:33)
• Case: A woman in her 60s with ICC with an IDH1 mutation (1:10:05)
• Emerging Role of HER2-Targeted Therapy for Advanced BTCs — Dr Harding (1:21:15)
• Case: A man in his early 40s with cholangiocarcinoma metastatic to the appendix (1:57:25)
• New Directions in the Management of BTCs — Dr Javle (2:01:09)

CME information and select publications